Found 14 matching trials
Tolerability and Efficacy of AM and PM Once Daily Dosing With Extended-release Guanfacine Hydrochloride in Children 6-12 With Attention-Deficit/Hyperactivity Disorder (ADHD) (The ADHD Tempo Study) PHASE3 The primary purpose is to assess the efficacy of once daily dosing with opt...
Show More Location
Clinical Study Centers, LLC
Learn More & Join Trial
Extended-release Guanfacine Hydrochloride in Children/Adolescents With Attention-deficit/Hyperactivity PHASE3 A study to evaluate the long term maintenance of efficacy of using Guanfaci...
Show More Location
Maastricht University Medical Centre
Learn More & Join Trial
Safety and Efficacy of SPD503 in Treating ADHD in Children and Adolescents Aged 6-17 PHASE3 The purpose of this study is to determine the efficacy of SPD503 compared t...
Show More Location
Multiple Locations
Learn More & Join Trial
Effect of Guanfacine Extended-Release on Attention Deficit Hyperactivity Disorder (ADHD)-Associated Insomnia PHASE4 This study seeks to determine, using special sleep tests (polysomnography a...
Show More Location
Children's Specialized Hospital
Learn More & Join Trial
SPD503 (Guanfacine Hydrochloride) in ADHD Plus Oppositional Symptoms PHASE3 To assess efficacy and safety of SPD503(guanfacine hydrochloride) in subjec...
Show More Location
HOPE Research Institute
Learn More & Join Trial
A Drug Interaction Study of SPD503 and Vyvanse Administered Alone and In Combination in Normal Healthy Volunteers PHASE1 Drug-drug interaction study; to examine the pharmacokinetics of SPD503 and ...
Show More Location
Advanced Biomedical Research, Inc.
Learn More & Join Trial
A Study of TAK-503 in Children and Teenagers With Attention Deficit Hyperactivity Disorder (ADHD) PHASE4 The main aim of this study is learn more about long-term TAK-503 treatment ...
Show More Location
Harmonex Neuroscience Research
Learn More & Join Trial
Safety and Efficacy of SPD503 in Treating Attention-Deficit/Hyperactivity Disorder (ADHD) in Children Aged 6-17 PHASE3 The purpose of this study is to assess the safety and efficacy of SPD503 (G...
Show More Location
Multiple Locations
Learn More & Join Trial
Safety, Tolerability and Efficacy of SPD503 in Treating ADHD in Children Aged 6-17 PHASE2 The purpose of this study is to determine the effects of SPD503 compared to...
Show More Location
Multiple Locations
Learn More & Join Trial
A Drug Interaction Study of SPD503 and Concerta Administered Alone and In Combination in Normal Healthy Volunteers PHASE1 This is a drug-drug interaction study; the purpose of this study is to exam...
Show More Location
Advanced Biomedical Research, Inc.
Learn More & Join Trial